On the other hand, enhanced c-MYC protein stability by NAD-dependent deacetylase sirtuin-2 (SIRT2) or inhibitor of nuclear factor kappa B kinase subunit epsilon (IKKε) has been demonstrated to increase pancreatic cancer tumorigenicity [10,62]. The gene discussed is MYC; the disease is pancreatic neoplasm.